Completed NA INTERVENTIONAL 4-arm NCT03249610

Randomized Control Trial for Overweight Employees in Worksites

Worksite Intervention Trial With Multi-Component Lifestyle Intervention and Digital Health Platform for Reduction of Body Weight and Cardio-metabolic Risk Factors

Sponsor: Abbott

Conditions Diabetes Mellitus, Type 2 Lifestyle Risk Reduction Metabolic Syndrome

Interventions Lifestyle intervention

Updated 7 times since 2017 Last updated: Aug 12, 2017 Started: Mar 11, 2014 Primary completion: Mar 12, 2017 Completion: Jun 15, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Diabetes Mellitus, Type 2 and Lifestyle Risk Reduction, this trial is completed. The trial is conducted by Abbott and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Oct 2021 [monthly]

Completed NA
Feb 2019 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Feb 2019 [monthly]

Completed NA
Sep 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott
Diabetes Foundation, India
Sprim Advanced Life Sciences

Data source: Diabetes Foundation, India

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.